A pharmaceutically acceptable salt of a b-site app cleaving enzyme inhibitor compound
PK201100319A0Undetermined Publication Date: 2011-05-11ELI LILLY & CO
0 Cites 0 Cited by
Patent Information
- Application Number
- PK201100319
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2011-04-30
- Publication Date
- 2011-05-11
Abstract
The present invention relates to a compound of Formula I for use in the treatment of Alzhiemer’s Disease and other diseases and, disorders involving amyloid-P(AP) peptide, aneurotoxic and highly aggregatory peptide segment of amyloid precursor protein (APP).
Need to check novelty before this filing date? Find Prior Art